Publication | Closed Access
A randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohns disease: Good safety profile but lack of efficacy
21
Citations
0
References
2010
Year
InflammationChronic Inflammatory DiseasesCrohns DiseaseBoswellia SerrataAnti-inflammatoryFunctional Gastrointestinal DisorderAlternative MedicineGastroenterologyClinical GastroenterologyGood Safety ProfileUlcerative ColitisComplementary TherapiesMedicineInflammatory Bowel DiseasesRheumatoid ArthritisComplementary Medicine
Introduction: Complementary therapies are frequently used by patients with inflammatory bowel diseases.